1. Home
  2. SKYE vs TLYS Comparison

SKYE vs TLYS Comparison

Compare SKYE & TLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.81

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$1.36

Market Cap

46.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYE
TLYS
Founded
2012
1982
Country
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
46.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SKYE
TLYS
Price
$0.81
$1.36
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$14.75
$2.25
AVG Volume (30 Days)
312.2K
44.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.57
52 Week High
$5.75
$4.40

Technical Indicators

Market Signals
Indicator
SKYE
TLYS
Relative Strength Index (RSI) 43.20 34.98
Support Level $0.70 $1.32
Resistance Level $1.07 $1.47
Average True Range (ATR) 0.08 0.07
MACD -0.01 -0.00
Stochastic Oscillator 35.22 28.26

Price Performance

Historical Comparison
SKYE
TLYS

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

Share on Social Networks: